Malignant rhabdoid tumor of the vulva. Case report

M. Bilal Sert, M. Onsrud, T. Perrone, F. Abbas, J. L. Currie

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


The poor prognosis of malignant rhabdoid tumor is emphasized and histopathological criteria for distinction from epithelial sarcoma of the vulva are discussed. Immunohistochemical analyses were performed by using nine different antigens including vimentin, cytokeratin, epithelial membrane antigen, carcinoembryonic antigen, desmin, muscle-specific actin, S-100 protein, AP-15, neuron specific enolase. This is the sixth reported case of a malignant rhabdoid tumor of the vulva. The patient died eight months after the initial diagnosis in spite of a combination of surgery, adjuvant chemotherapy and external radiotherapy.

Original languageEnglish (US)
Pages (from-to)258-261
Number of pages4
JournalEuropean Journal of Gynaecological Oncology
Issue number4
StatePublished - 1999
Externally publishedYes


  • Malignant rhabdoid tumor
  • Treatment
  • Vulva

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology


Dive into the research topics of 'Malignant rhabdoid tumor of the vulva. Case report'. Together they form a unique fingerprint.

Cite this